RabAvert (GSK Vaccines GmbH)
Welcome to the PulseAid listing for the RabAvert drug offered from GSK Vaccines GmbH. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | GSK Vaccines GmbH |
| NON-PROPRIETARY NAME: | Rabies Vaccine |
| SUBSTANCE NAME: | |
| TYPE: | VACCINE |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-07-08 |
| END MARKETING DATE: | 2020-03-31 |
RabAvert VACCINE Details:
| Item Description | RabAvert from GSK Vaccines GmbH |
| LABELER NAME: | GSK Vaccines GmbH |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2014-07-08 |
| END MARKETING DATE: | 2020-03-31 |
| PRODUCT ID: | 63851-501_1e6d0596-d032-4f29-a94b-ca5ce32abe23 |
| PRODUCT NDC: | 63851-501 |
| APPLICATION NUMBER: | BLA103334 |